Coordination Chemistry of Microbial Iron Transport Compounds
Coordination Chemistry of Microbial Iron Transport Compounds
批准号:
8196708
负责人:
KENNETH N RAYMOND
金额:
$36.51万
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-04-01 至 2013-11-30
关键词:
AddressAffectAffinityAttentionAwarenessBacillus (bacterium)Bacillus anthracisBacteriaBindingBiochemistryCell physiologyCellsChelating AgentsChemistryCollaborationsComplementComplexEnsureEnvironmentExposure toFamilyGoalsGram-Negative BacteriaGram-Positive BacteriaGrantGrowthHumanImmune responseImmune systemInfectionInorganic ChemistryInvadedIronIsotope LabelingKineticsLabelLaboratoriesLightMediatingMembraneMembrane ProteinsMetalsMicrobiologyModificationMolecular WeightNutrientOrganismPhysiologicalProcessProductionProteinsReportingRoleSepsisSiderophoresStagingStructureSystemTechniquesTemperatureThermodynamicsVirulenceabstractinganalogdesignlipophilicitymeetingsmicrobialmicroorganismmutantpathogenpressurereceptorresearch studysiderophore receptorstooluptake
中文摘要
项目总结/摘要
在美国,每年报告近50万例细菌性败血症,
这些病例是致命的。铁是微生物生长中的限制性营养素;细菌主要通过以下途径获得铁:
生产铁载体,具有高铁亲和力和选择性的低分子量螯合剂。的
铁的可用性在确定入侵病原体的毒力方面是必不可少的。最成功的
人类病原体,如炭疽杆菌,设计了复杂的,多方面的策略,以确保其
铁供应。该项目旨在了解铁载体转运系统:1)从结构水平,
研究铁结合的热力学和动力学,2)在系统水平上,
将这些铁载体运输到细菌中,3)到环境水平,探索周围环境如何,
例如温度、宿主免疫系统、其他细菌的存在,甚至暴露于光下,
细菌的生长。我们的实验室配备了独特的设备来进行这一系列的研究,
具体目标如下:1.了解结构与功能的关系,
铁载体2.研究革兰氏阳性菌铁载体介导的铁转运。3.探讨
微生物铁运输的铁载体穿梭机制的范围和功能。4.进一步
描述了人类免疫系统蛋白质(铁载体)识别铁载体的机制
以及这种免疫反应的选择性如何被最危险的细菌病原体利用。
为了满足这些目的,铁载体的特征,如热力学稳定性和还原电位,
铁载体铁络合物,其铁结合动力学和亲脂性,将被确定为靶向的
铁载体,并通过构建合成的铁载体类似物和配位类似物,我们将
探讨铁载体功能。几乎所有关于细菌铁载体介导的铁
运输是在革兰氏阴性菌;革兰氏阳性菌现在是我们的目标,因为这组
生物体包括许多重要的人类病原体。我们有适当的合作,以确定
芽孢杆菌属物种的膜相关蛋白受体的晶体结构,
我们的研究在这个家庭。我们首次报道的铁载体穿梭机制表明,金属交换
在研究的革兰氏阴性细菌中,两个铁载体之间的相互作用对于铁的运输是必不可少的。我们计划
看看这种机制在细菌属中的分布有多广泛;我们现在提出一种扩展的
实验方法,包括使用同位素标记的天然铁载体。我们最近
开始了解我们所谓的“铁载体隐形”:逃避铁载体结合,
铁载体的结构修饰。通过使用合成类似物和细菌铁载体
分离物,以及标记的底物和突变蛋白,我们打算描述的选择性和
铁素的生理过程
英文摘要
Project Summary/Abstract
Nearly half a million cases of bacterial sepses are reported annually in the USA and approximately one third of
the cases are fatal. Iron is a limiting nutrient in microbial growth; bacteria primarily obtain iron through
production of siderophores, low molecular weight chelating agents with high ferric affinity and selectivity. The
availability of iron is essential in determining the virulence of an invading pathogen. The most successful
human pathogens, such as Bacillus anthracis, devise elaborate, multifaceted strategies to ensure their
iron supply. This project seeks to understand siderophore transport systems: 1) from a structural level,
studying the thermodynamics and kinetics of iron binding, 2) to a systemic level, following the recognition and
transport of these siderophores into the bacteria, 3) to an environmental level, exploring how the surroundings,
such as temperature, host immune system, presence of other bacteria and even exposure to light, affect the
growth of the bacteria. We are uniquely equipped in our laboratory to carry out this range of studies and to
pursue the following specific aims: 1. To understand the relationship between structure and function of
siderophores. 2. To characterize siderophore-mediated iron transport in Gram-positive bacteria. 3. To explore
the scope and functioning of the siderophore shuttle mechanism of microbial iron transport. 4. To further
describe the mechanism of recognition of siderophores by proteins of the human immune system (siderocalin)
and how the selectivity of this immune response is exploited by the most dangerous bacterial pathogens.
To meet these Aims siderophore features such as thermodynamic stability and reduction potential of
siderophore ferric complex, their kinetics of iron binding, and lipophilicity, will be determined for targeted
siderophores and through the construction of synthetic siderophore analogs and coordination analogs we will
explore siderophore function. Almost everything that is known about bacterial siderophore-mediated iron
transport is in Gram-negative bacteria; Gram-positive bacteria are now our target, since this group of
organisms includes many important human pathogens. We have in place collaborations to determine the
crystallographic structures of membrane-associated protein receptors of Bacillus species that will complement
our studies in this family. Our first report of the siderophore shuttle mechanism showed that metal exchange
between two siderophores was essential for iron transport in the Gram-negative bacteria studied. We plan to
see how widely distributed is this mechanism is among genera of bacteria; we now propose an extended
experimental approach that incorporates the use of isotopically labeled natural siderophores. We have recently
begun to develop an understanding of what we call "siderophore stealth": the evasion of siderocalin binding by
structural modification of the siderophore. Through the use of synthetic analogs and bacterial siderophore
isolates, as well as labeled substrates and mutant proteins, we intend to describe the selectivity and
physiological course of siderocalin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A proposal for the purchase of a new Cu anode Microsource X-ray Diffractometer wi
-
批准号:7794643
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:KENNETH N RAYMOND
-
依托单位:
Biomimetic Lanthanide & Actinide Decorporation Agents: Preclinical Development
-
批准号:7585996
-
项目类别:
-
资助金额:$87.85万
-
财政年份:2006
-
负责人:KENNETH N RAYMOND
-
依托单位:
Biomimetic Lanthanide & Actinide Decorporation Agents: Preclinical Development
-
批准号:7267890
-
项目类别:
-
资助金额:$99.83万
-
财政年份:2006
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes:MRI Agents
-
批准号:6865433
-
项目类别:
-
资助金额:$22.18万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes: MRI Agents
-
批准号:7885681
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes: MRI Agents
-
批准号:7588891
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes:MRI Agents
-
批准号:6456410
-
项目类别:
-
资助金额:$22.18万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes: MRI Agents
-
批准号:7021488
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes: MRI Agents
-
批准号:7189046
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes:MRI Agents
-
批准号:6622801
-
项目类别:
-
资助金额:$22.18万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes: MRI Agents
-
批准号:8239545
-
项目类别:
-
资助金额:$36.28万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes: MRI Agents
-
批准号:8446431
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes:MRI Agents
-
批准号:6725399
-
项目类别:
-
资助金额:$22.18万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes: MRI Agents
-
批准号:8035401
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
Hydroxypyridonate Gd Complexes: MRI Agents
-
批准号:7385052
-
项目类别:
-
资助金额:$23.52万
-
财政年份:2002
-
负责人:KENNETH N RAYMOND
-
依托单位:
THERAPEUTIC MULTIDENTATE IRON SEQUESTERING AGENTS
-
批准号:6381827
-
项目类别:
-
资助金额:$22.04万
-
财政年份:2000
-
负责人:KENNETH N RAYMOND
-
依托单位:
THERAPEUTIC MULTIDENTATE IRON SEQUESTERING AGENTS
-
批准号:6090906
-
项目类别:
-
资助金额:$24.58万
-
财政年份:2000
-
负责人:KENNETH N RAYMOND
-
依托单位:
Therapeutic Multidentate Iron Sequestering Agents
-
批准号:7251936
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2000
-
负责人:KENNETH N RAYMOND
-
依托单位:
Therapeutic Multidentate Iron Sequestering Agents
-
批准号:7098678
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2000
-
负责人:KENNETH N RAYMOND
-
依托单位:
THERAPEUTIC MULTIDENTATE IRON SEQUESTERING AGENTS
-
批准号:6635274
-
项目类别:
-
资助金额:$21.99万
-
财政年份:2000
-
负责人:KENNETH N RAYMOND
-
依托单位:
海外基金